# EDGAR Filing Document

**Accession Number:** 0001900304
**File Stem:** 0001654954-26-004034
**Filing Date:** 2026-4
**Character Count:** 5272
**Document Hash:** 1e53f8723e095bff9f2c8c869794fe4c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001654954-26-004034.hdr.sgml**: 20260429

**ACCESSION NUMBER**: 0001654954-26-004034

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 3

**CONFORMED PERIOD OF REPORT**: 20260429

**FILED AS OF DATE**: 20260429

**DATE AS OF CHANGE**: 20260429

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Haleon plc
- **CENTRAL INDEX KEY:** 0001900304
- **STANDARD INDUSTRIAL CLASSIFICATION:** PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** X0
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41411
- **FILM NUMBER:** 26910262

**BUSINESS ADDRESS:**
- **STREET 1:** BUILDING 5, FIRST FLOOR
- **STREET 2:** THE HEIGHTS
- **CITY:** WEYBRIDGE
- **STATE:** X0
- **ZIP:** KT13 0NY
- **BUSINESS PHONE:** 44 1932 822000

**MAIL ADDRESS:**
- **STREET 1:** BUILDING 5, FIRST FLOOR
- **STREET 2:** THE HEIGHTS
- **CITY:** WEYBRIDGE
- **STATE:** X0
- **ZIP:** KT13 0NY

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** DRVW 2022 Ltd
- **DATE OF NAME CHANGE:** 20211217

 **UNITED STATES**

 **SECURITIES AND EXCHANGE COMMISSION**

 **Washington, D.C. 20549**

 **FORM 6-K**

 **REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934**

 **For the month of April 2026**

 **Commission File Number: 001-41411**

 **Haleon plc**

(Translation of registrant's name into English)

 **Building 5, First Floor, The Heights,**

 **Weybridge, Surrey, KT13 0NY**

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒ Form 40-F ☐

 **EXHIBIT INDEX**

---

| | |
|:---|:---|
| <u>Exhibit Number</u> | <u>Description</u> |
| 99.1 | 29 April 2026 - "Haleon 2026 Q1 Trading Statement" |
| [99.2](a260429q12026pressrelease.pdf) | 29 April 2026 - "[Haleon 2026 Q1 Trading Statement](a260429q12026pressrelease.pdf)" |

---

99.1 ![](a2900c000.jpg)

 **Haleon plc: 2026 Q1 Trading Statement**

 **29 April 2026:** Haleon plc (the "Company" or "Haleon") today announces its Q1 trading statement for the year ending 31 December 2026 is available at: <u>http://www.rns-pdf.londonstockexchange.com/rns/2888C_1-2026-4-28.pdf</u> .

The Q1 trading statement will also be available on the Haleon website <u>www.haleon.com/investors</u>, and has been submitted in full unedited text to the Financial Conduct Authority's National Storage Mechanism and will shortly be available for inspection at <u>https://data.fca.org.uk/#/nsm/nationalstoragemechanism</u>.

 **Presentation for analysts and shareholders**

A short presentation followed by Q&A will be hosted by Brian McNamara, Chief Executive Officer, and Dawn Allen, Chief Financial Officer at 9:00am BST (10:00am CEST) on 29 April 2026, which can be accessed at <u>www.haleon.com/investors/</u>.

For analysts and shareholders wishing to ask questions on the Q&A call, please use the dial-in details below which will have a Q&A facility:

---

| | |
|:---|:---|
| UK: | +44 (0) 808 189 0158  |
| US: | +1 855 979 6654 |
| All other: | +44 (0) 203 936 2999 |
| Passcode: | 975813 |

---

An archived webcast of the Q&A call will be available later on the day of the results and can be accessed at <u>www.haleon.com/investors</u><u>.</u>

 **Amanda Mellor** 

 **Company Secretary** 

 **Enquiries**

---

| | | | |
|:---|:---|:---|:---|
| **Investors** | **Investors** | **Media** | **Media** |
| Jo Russell | +44 7787 392441 | Zoë Bird | +44 7736 746167 |
| Rakesh Patel  | +44 7552 484646 | Victoria Durman | +44 7894 505730 |
| <br> Email: investor-relations@haleon.com | <br> Email: investor-relations@haleon.com | <br> Email: corporate.media@haleon.com | <br> Email: corporate.media@haleon.com |

---

 **About Haleon**

Haleon (LSE/NYSE: HLN) is a consumer company that is solely focused on better everyday health. Our people, our brands, our research, our investment and our innovation are aimed at improving the everyday health of consumers. Our product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Our superior brands - such as *Advil*, *Centrum*, *Otrivin*, *Panadol*, *parodontax*, *Polident*, *Sensodyne*, *Theraflu* and *Voltaren* - are trusted by more than one billion consumers and are recommended by health professionals around the world.

For more information, please visit <u>www.haleon.com</u>.

 **SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
|  |  | **HALEON PLC**<br> *(Registrant)* | **HALEON PLC**<br> *(Registrant)* |
| Date: April 29, 2026 | By: | /s/ Amanda Mellor | /s/ Amanda Mellor |
|  |  | Name: | Amanda Mellor |
|  |  | Title: | Company Secretary |

---

### Attached PDF Documents

**Attachment 1:** `a260429q12026pressrelease.pdf`

_No text found in this document._